Optimization and Mechanistic Investigations of Novel Allosteric Activators of PKG1α
WuXi AppTec scientists recently contributed to a research article in the Journal of Medicinal Chemistry describing the optimization of a piperidine series of small molecules as novel allosteric activators of PKG1α (a compelling drug target for treatment of cardiovascular diseases). This study reveals a mechanism of action for these compounds consistent with cGMP-induced activation, including antiproliferative effects in human pulmonary arterial smooth muscle cells.
https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c02109
Related Content
Current preclinical murine models of heart failure with preserved ejection fraction (HFpEF) require prolonged modeling periods, posing significant challenges for...
VIEW RESOURCEInternational Women's Day: Safeguarding Women's Health Across the Lifespan with the Power of Science
Introduction In recognition of International Women's Day, we spotlight women's health—a continuously evolving global healthcare issue. The year 2025 marks...
VIEW RESOURCE
